Financing, Equity Capital Markets
Inozyme Pharma, Inc.
07/23
|
$60.0 Million
![Inozyme](/sites/default/files/images/custom/Inozyme-Pharma.png)
Piper Sandler served as bookrunner for Inozyme Pharma, Inc. on a confidentially marketed follow-on offering